Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CVS · against 28 other Healthcare companies of similar size
Ranked #20 of 29 · scores higher than 32% of peers · safety percentile 23
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)8 peers with a safety percentile of 20–29, including CVS · Click a bar to see the companies
Mainly because of its current ratio and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CVS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 24 reported | 0.96× | 0.64× | 22% | 33% | |
| BetaLower is better · 29 reported | 0.60 | 0.50 | 25% | 33% | |
| Current ratioHigher is better · 29 reported | 0.87× | 1.27× | 14% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 100.2B USD | 77 | 68 | |
| 2 | 11.26T JPY (≈$76.6B) | 74 | 72 | |
| 3 | 134.5B USD | 72 | 70 | |
| 4 | 534.1B HKD (≈$68.4B) | 58 | 75 | |
| 5 | 108.6B USD | 51 | 66 | |
| 16 | 189.3B USD | 30 | 45 | |
| 17 | 78.1B USD | 30 | 60 | |
| 18 | 89.7B USD | 27 | 50 | |
| 19 | 95.4B AUD (≈$62.9B) | 24 | 48 | |
| 20 | 116.9B USD | 23 | 47 | |
| 21 | 540.4B BRL (≈$97.3B) | 21 | 64 | |
| 21 | 162.93T ARS (≈$162.9B) | 21 | 63 | |
| 23 | 97.5B USD | 20 | 67 | |
| 24 | 66.3B USD | 20 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score